UPDATE: Goldman Sachs Starts Amylyx Pharmaceuticals inc. (AMLX) at Buy
Tweet Send to a Friend
(Updated - February 1, 2022 4:20 AM EST)
Goldman Sachs analyst Chris Shibutani initiates coverage on Amylyx Pharmaceuticals inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Chris Shibutani initiates coverage on Amylyx Pharmaceuticals inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
